Skip to main content
. 2021 Jul 16;23(9):125. doi: 10.1007/s11886-021-01556-6

Table 1.

Currently available devices for transcatheter mitral valve repair with a CE mark

graphic file with name 11886_2021_1556_Tab1_HTML.jpg

*Based on COAPT criteria: patients on maximized HF therapy including CRT and with large SMR in relation to LV dimensions

**NeoChord figure is used with permission from NeoChord, Inc.

RCT randomized controlled trial, PMR primary mitral regurgitation, SMR secondary mitral regurgitation, TsP transseptal puncture, LV left ventricle